Jennifer J. Hu, Ph.D.
- Fax: 305-243-2997
- Professor, Department of Biochemistry and Molecular Biology
- Professor, Department of Public Health Sciences, Division of Epidemiology & Population Health Sciences
• Cancer Health Disparities
• DNA Repair in Cancer Risk and Treatment
• Genomics in Cancer Diagnosis and Prognosis
• Precision Cancer Therapies
• Targeted Cancer Intervention
Georgetown University Medical School
UMDNJ-New Jersey Medical School
University of Louisiana
Fu-Jen Catholic University
Dr. Hu is a Professor in the Departments of Public Health Sciences, Biochemistry and Molecular Biology, and Human Genetics and Genomics. As a trans-disciplinary cancer researcher, she has training in basic sciences (Ph.D. in Biochemistry and Molecular Biology) and cancer epidemiology (M.S. in Biostatistics and Epidemiology) and her research mainly focuses on the molecular and genetic mechanisms of breast cancer risk and survival disparities and implication of DNA damage and repair in precision medicine. The pioneer research from her laboratory and collaborative effort that has significant impact on the cancer research field include: (1) deficient DNA repair and elevated DNA damage in human breast and prostate cancer risk; (2) racial/ethnic specific polygenic models of DNA repair in human cancer risk and tumor TP53 mutations; (3) functional implication of DNA repair genotypes in human cancer risk and targeted therapies; (4) gene-diet interactions in human colon and breast cancer risk; and (5) genome-wide association studies of novel breast cancer and ER-negative breast cancer susceptibility loci in women of African ancestry. She is the course director for Molecular and Genetic Epidemiology and Cancer Epidemiology and Prevention. Her research program has been continuously funded for more than 20 years with peer-reviewed grants from NIH/NCI/ACS/DOD/FL since 1992. Her broad scientific expertise includes basic laboratory research in DNA damage/repair, molecular and genetic epidemiology, genomic prediction models of survival, precision medicine, and cancer health disparities. With her diverse research background and strong commitment in training/education, she has successfully mentored a number of young scientists with outstanding career development. She has served on more than 50 NIH/NCI/DOD study sections; became a regular member of the NCI subcommittee F for training grants in 2013 and the chair of the DOD prostate cancer research study section since 2011.